Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 1;108(10):2855-2858.
doi: 10.3324/haematol.2022.281973.

The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status

Affiliations

The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status

Man-Chiu Poon et al. Haematologica. .
No abstract available

PubMed Disclaimer

References

    1. Poon MC, d'Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: focus on Glanzmann's thrombasthenia and Bernard-Soulier's syndrome. Semin Thromb Hemost. 2018;44(6):604-614. - PubMed
    1. Novo Nordisk. NovoSeven®, Summary of product characteristics. 2023. https://www.ema.europa.eu/en/documents/product-information/novoseven-epa.... Accessed 20 February 2023.
    1. Di Minno G, Zotz RB, d'Oiron R, et al. . The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia. Haematologica. 2015;100(8):1031-1037. - PMC - PubMed
    1. Poon MC, d'Oiron R, Zotz RB, et al. . The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Haematologica. 2015;100(8):1038-1044. - PMC - PubMed
    1. EMA. Assessment report NovoSeven. https://www.ema.europa.eu/en/documents/variation-report/novoseven-h-c-00.... Accessed 16 March 2023.

Associated data